1 of 1
Story summary
- Ginkgo Bioworks recently collaborated with OpenAI to use GPT-5 in protein synthesis experiments, achieving a 40% cost reduction versus prior methods.
- Ginkgo Bioworks was founded in 2008 by MIT scientists to revolutionize biology through automation and AI.
- The company developed Reconfigurable Automation Carts (RACs) to enhance lab efficiency.
- Human oversight remains crucial for the autonomous lab system that combines AI and robotics.
